Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

GN Tops OMXC20 as Morgan Stanley Sees Gains: Copenhagen Mover

GN Store Nord A/S topped gainers in Copenhagen’s benchmark index after Morgan Stanley said Denmark’s second-largest hearing aid maker will perform better than rivals William Demant A/S and Sonova Holding AG.

GN, based in Ballerup, Denmark, gained 1.1 percent to 109 kroner, making it the best performing stock in the OMX Copenhagen 20 index. Trading volume was 9 percent of the three-month daily average at 9:52 a.m. local time.

GN unveiled new additions earlier this month to its ReSound Verso hearing aid series at the American Academy of Audiology annual meeting. The “unique” product will help the device maker gain market share at the expense of Copenhagen-based Demant as new tenders are put out, Morgan Stanley analyst Michael Jungling said in a note today to clients.

“We would classify 2013 as a big tender year,” Jungling said. “Given the relatively smaller size, GN would see the biggest potential boost compared to Sonova and William Demant.”

The company’s forecast for sales growth of 4 percent to 6 percent is “conservative,” Jungling said. He has an overweight recommendation on GN and a price target of 115 kroner. Revenue may increase even more than his estimate of 6.7 percent, he said.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.